Adventist Health System/ West
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), Adventist Health System/ West reported 7 stock positions worth $615.9 million. Its top holding was iShares Core S&P 500 ETF (IVV) at 58.3% of the portfolio, followed by iShares Core MSCI Emerging (IEMG, 9.3%) and Vanguard Ftse Developed ETF (VEA, 9.1%). Compared with Q1 2024, it opened 3 new positions, sold out of 1 and reduced 1. The biggest buy was a new position in Vanguard Ftse Developed ETF (VEA) and the biggest sale an exit from iShares Core MSCI Eafe ETF (IEFA).
- Most Recent 13F
- Q2 2026
- Location
- Roseville, CA
- CIK
- 0001802516
- Portfolio Value
- $615.9M (Q2 2024)
- SEC Filing
- 0001172661-24-003288 ↗ filed Aug 13, 2024
Holdings Value
Holdings 7 stocks · $615.9M
| IVV iShares Core S&P 500 ETF | 58.26% | 653,500 | $358.8M | Reduce -0.1% |
| IEMG iShares Core MSCI Emerging | 9.28% | 1,067,519 | $57.1M | No change |
| VEA Vanguard Ftse Developed ETF | 9.08% | 1,131,440 | $55.9M | New |
| VONV Vanguard Russell 1000 Value | 8.61% | 692,800 | $53.0M | No change |
| VTIP Vanguard Short-Term Tips | 7.62% | 966,530 | $46.9M | No change |
| VOT Vngrd Mrngstr MC GRW ETF-Usd | 4.89% | 131,150 | $30.1M | New |
| VBK Van Morst SML-Cap Gro-Usd Inc. | 2.26% | 55,720 | $13.9M | New |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $638.1M | IVV, VEA, VONV, IXUS, ITOT |
| Q1 2026 | 13 | $563.9M | IVV, VEA, VONV, IXUS, ITOT |
| Q4 2025 | 8 | $595.0M | IVV, VEA, VONV, ITOT, VTIP |
| Q3 2025 | 8 | $613.9M | VOO, VEA, ITOT, VONV, VTIP |
| Q2 2025 | 8 | $673.3M | VOO, IVV, VEA, VONV, EMXC |
| Q1 2025 | 8 | $633.7M | VOO, IVV, IEMG, VEA, VONV |
| Q4 2024 | 8 | $646.5M | VOO, IVV, VONV, IEMG, VEA |
| Q3 2024 | 7 | $650.2M | IVV, IEMG, VEA, VONV, VTIP |
| Q2 2024 | 7 | $615.9M | IVV, IEMG, VEA, VONV, VTIP |
| Q1 2024 | 5 | $556.2M | IVV, IEFA, IEMG, VONV, VTIP |